News

MUST READS

A November 23, 2016 Reuters article reported that “Eli Lilly and Co said its experimental Alzheimer's treatment failed to slow loss of cognitive ability in patients with mild symptoms, a major setback for the company and millions of people at risk of developing the memory-robbing disease.”

MUST READS

MUST READS

MUST READS

USA2 SPOTLIGHT 

TODAY: Together with WomenAgainstAlzheimer’s, we are hosting a Twitter Chat with USA Today to elevate the conversation about Alzheimer’s impact on women. We hope you can join us this Wednesday 11/16 from 1 – 2 pm ET to amplify our collective voice! What should you do? Jump on Twitter at 1 pm ET and use the hashtag #hope4alz to respond to the moderator, ask questions, and provide your own thoughts and views.

Pages

^ Back to Top